-
1
PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer
Published 2024-09-01Subjects: Get full text
Article -
2
A new insight into the impact of copy number variations on cell cycle deregulation of luminal-type breast cancer
Published 2025-02-01Subjects: Get full text
Article